You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Valuation is a hot topic among life sciences professionals. There is no clear understanding on how to use the different valuation approaches and how to determine input parameters. Some do not value at all, arguing that it is not possible to get realistic and objective numbers out of it. Some claim it to be an art. In the following chapters we will provide the user with a concise val- tion manual, providing transparency and practical insight for all dealing with valuation in life sciences: project and portfolio managers, licensing executives, business developers, technology transfer managers, entrep- neurs, investors, and analysts. The purpose of the book is to explain how to apply discounted...
Silicon Valley University of Evolutionary Computation (SUEC) has been established in 2022 in a secluded location in the hills above Redwood city, California. Evolutionary computation is an area of computer sciences that uses principles from biological evolution to solve computational problems. Many of the tech tools developed and explored at SUEC are years ahead of what is available anywhere else. For example, SUEC researchers developed brain-chip-interfaces, which exponentially enhance human brain capacity. On May 24, 2032, newly developed brain chips were stolen at SUEC University. This incident led to 10 major injuries, 5 hospitalizations and 3 deaths. Dr. Lili Pham, radiologist at SUEC hospital, and an FBI investigator team started a race against time to rescue a young student from a ruthless killer, retrieve a national treasure and prevent an implosion of the most eminent University in the world.
"Pharmaceutical Science: Quality, Regulation, and Drug Development" provides a comprehensive examination of the multifaceted world of pharmaceutical science, with a special focus on quality assurance, regulatory requirements, and drug development processes. This book is an essential resource for every professional, providing detailed insights into critical aspects of the pharmaceutical industry. The text carefully covers the quality control measures and standards required to ensure the efficacy and safety of pharmaceutical products. It goes deep into regulatory frameworks, detailing the stringent guidelines and processes that govern drug approval and market entry, with an emphasis on both gl...
This is the first complete guide to valuation in life sciences for industry professionals, investors, and academics. Boris Bogdan and Ralph Villiger introduce the characteristics of drug and medical device development, explain how to translate these into the valuation, and provide valuable industry data. Special emphasis is put on the practicability of the proposed methods by including many hands-on examples, without compromising on realistic results.
"Beginning in the 1970s, several scientific breakthroughs promised to transform the creation of new medicines. As investors sought to capitalize on these Nobel Prize-winning discoveries, the biotech industry grew to thousands of small companies around the world. Each sought to emulate what the major pharmaceutical companies had been doing for a century or more, but without the advantages of scale, scope, experience, and massive resources. How could a large collection of small companies, most with fewer than 50 employees, compete in one of the world's most breathtakingly expensive and highly regulated industries? This book shows how biotech companies have met the challenge by creating nearly ...
I thought I could leave my dark past behind. Then I met her. Pure, innocent, and untouched, she's everything I never knew I wanted. Everything I never deserved. When those scumbags snatch her away from me, all bets are off. They’re planning to sell her. I thought I was done with this life. The killing, the bloodshed, the darkness. But I have no choice. Her kidnappers don’t know who I am, or the lives I’ve taken. Soon they’ll learn. I’ll use every last one of my illicit skills to outsmart them. I'll stop at nothing to rescue her, even if it means going up against the most dangerous criminals in the world. Once I have her back in my arms, I'll have to fight another battle - to make h...
This book is the first complete guide to valuation in life sciences for industry professionals, investors, and academics. It introduces the characteristics of drug and medical device development, explains how to translate these into the valuation, and provides valuable industry data. Special emphasis is put on the practicability of the proposed methods by including many hands-on examples, without compromising on realistic results.
Intellectual property is a vital part of the global economy, accounting for about half of the GDP in countries like the United States. Innovation, competition, economic growth and jobs can all be helped or hurt by different approaches to this key asset class, where seemingly slight changes in the rules of the game can have remarkable impact. This book brings together diverse perspectives from the fields of law, economics, business and political science to explore the ways varying approaches to intellectual property can positively and negatively impact our economy and society. Employing approaches that are both theoretically rigorous and grounded in the real world, Perspectives on Commercializing Innovation is well suited for practising lawyers, managers, lawmakers and analysts, as well as academics conducting research or teaching in a range of courses in law schools, business schools and economics departments, at either the undergraduate or graduate level.